<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Li L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Interleukin-28A (IL-28A or interferon-λ2) is reported to maintain intestinal mucosal homeostasis. However, the effects and mechanisms of IL-28A on intestinal ischemia reperfusion (I/R) have not yet been studied.&lt;h4>Methods&lt;/h4>Adult C57BL/6 mice were randomly divided into three groups: sham, I/R, and I/R+IL-28A (n=5 in each group). The I/R+IL-28A group mice were injected with recombinant mouse IL-28A 12 hours before the operation. Mice were sacrificed 6 hours after reperfusion. The mucosal permeability was investigated, and histology analyses were performed. Additionally, a hypoxic Caco-2 cell culture model was established. Fludarabine was used to inhibit phosphorylated signal transducer and activator of transcription 1 (pSTAT1). The expression of IL-28A, tight junctions (TJs), and pSTAT1 was assessed by western blot, immunohistochemical (IHC) staining, or immunofluorescence staining. Epithelial permeability was measured by transepithelial electrical resistance (TER).&lt;h4>Results&lt;/h4>The expression of IL-28A was decreased in intestinal lamina propria in the I/R group compared with the control group. Administration of IL-28A significantly alleviated the I/R-induced increase in intestinal permeability and tissue damage. Treatment with IL-28A significantly attenuated intestinal I/R-induced disruption of TJ proteins, including zonula occludens-1 (ZO-1), occludin, and claudin-1. &lt;i>In vitro&lt;/i>, IL-28A treatment reversed the decrease in TER of Caco-2 monolayers exposed to hypoxic environments. IL-28A led to the activation of STAT1 and the upregulation of claudin-1 expression both &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i>. Also, inhibiting phosphorylation of STAT1 reversed the effects of IL-28A on the expression and distribution of claudin-1 in Caco-2 cells.&lt;h4>Conclusions&lt;/h4>Intestinal epithelial barrier dysfunction caused by intestinal I/R is ameliorated by IL-28A via the regulation of claudin-1.</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>365</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8033364</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Interleukin-28A maintains the intestinal epithelial barrier function through regulation of claudin-1.</pubmed_title><pmcid>PMC8033364</pmcid><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Yu M</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Xiao W</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interleukin-28A maintains the intestinal epithelial barrier function through regulation of claudin-1.</name><description>&lt;h4>Background&lt;/h4>Interleukin-28A (IL-28A or interferon-λ2) is reported to maintain intestinal mucosal homeostasis. However, the effects and mechanisms of IL-28A on intestinal ischemia reperfusion (I/R) have not yet been studied.&lt;h4>Methods&lt;/h4>Adult C57BL/6 mice were randomly divided into three groups: sham, I/R, and I/R+IL-28A (n=5 in each group). The I/R+IL-28A group mice were injected with recombinant mouse IL-28A 12 hours before the operation. Mice were sacrificed 6 hours after reperfusion. The mucosal permeability was investigated, and histology analyses were performed. Additionally, a hypoxic Caco-2 cell culture model was established. Fludarabine was used to inhibit phosphorylated signal transducer and activator of transcription 1 (pSTAT1). The expression of IL-28A, tight junctions (TJs), and pSTAT1 was assessed by western blot, immunohistochemical (IHC) staining, or immunofluorescence staining. Epithelial permeability was measured by transepithelial electrical resistance (TER).&lt;h4>Results&lt;/h4>The expression of IL-28A was decreased in intestinal lamina propria in the I/R group compared with the control group. Administration of IL-28A significantly alleviated the I/R-induced increase in intestinal permeability and tissue damage. Treatment with IL-28A significantly attenuated intestinal I/R-induced disruption of TJ proteins, including zonula occludens-1 (ZO-1), occludin, and claudin-1. &lt;i>In vitro&lt;/i>, IL-28A treatment reversed the decrease in TER of Caco-2 monolayers exposed to hypoxic environments. IL-28A led to the activation of STAT1 and the upregulation of claudin-1 expression both &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i>. Also, inhibiting phosphorylation of STAT1 reversed the effects of IL-28A on the expression and distribution of claudin-1 in Caco-2 cells.&lt;h4>Conclusions&lt;/h4>Intestinal epithelial barrier dysfunction caused by intestinal I/R is ameliorated by IL-28A via the regulation of claudin-1.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T21:25:04.615Z</modification><creation>2025-04-04T21:25:04.615Z</creation></dates><accession>S-EPMC8033364</accession><cross_references><pubmed>33842586</pubmed><doi>10.21037/atm-20-5494</doi></cross_references></HashMap>